D
Arcturus Therapeutics Holdings Inc. ARCT
$18.51 $1.035.89% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -9.18M -14.08M -30.01M -6.90M -17.22M
Total Depreciation and Amortization 779.00K 801.00K 819.00K 912.00K 909.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.33M 6.68M 8.81M 9.70M 9.81M
Change in Net Operating Assets -3.68M -28.55M 20.09M -27.47M -23.65M
Cash from Operations -5.76M -35.14M -284.00K -23.76M -30.14M
Capital Expenditure 0.00 -137.00K 0.00 -80.00K -328.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 0.00 -137.00K 0.00 -80.00K -328.00K
Total Debt Issued 0.00 15.00M -- -- --
Total Debt Repaid -15.00M -- -- -- --
Issuance of Common Stock 274.00K 195.00K 134.00K 693.00K 2.40M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -14.73M 15.20M 134.00K 693.00K 2.40M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -20.48M -20.08M -150.00K -23.15M -28.07M